Clinical Trials Browser

Essential Hypertension × candesartan × Endocrine × Clear all

NCT01629225 2014-11-18

GRK4 Polymorphisms Blood Pressure Response to Candesartan

Phase 4 Unknown

Essential Hypertension, Multiple Endocrine Neoplasia Type 1